Objective To study the overweight or obesity on bronchial asthma treatment effects, explore its correlation. Methods Based on the body mass index in patients with different will be divided into A group, B group, observe two groups of patients with autoimmune condition and the treatment of difference; according to patients condition will be divided into severe group C and mild to moderate group D, comparing the two groups of patients with the condition and the treatment of difference. Results In A group, the average age of patients, severe/critical incidence probability, known allergen in proportion, the use of oral, inhaled corticosteroid hormone content were significantly greater in group B patients. C group compared with D group, the mean body mass index were 25.4and23.7, normal body mass index patients were respectively 52.9% and 65.8%. Conclusion Through this research, found that overweight or obese symptoms in patients with bronchial asthma clinical treatment has a negative influence.% 目的 研究超重或肥胖对支气管哮喘治疗的影响,探究其相互关联.方法 依据患者的体质量指数的不同将其分为A组、B组,观察两组患者的自身情况以及治疗差异；依据患者病情将其分为重度组C与轻中度组D,比较两组患者的自身情况以及治疗差异.结果 A组患者的平均年龄、出现重度/危重发病的概率、已知过敏原的比例、使用口服激素量、吸入激素量均明显大于B组患者.C组与D组相比,平均体质量指数分别为25.4与23.7,正常体质量指数的患者分别为52.9%和65.8%.结论 通过本文研究,发现超重或肥胖的体征对支气管哮喘患者的临床治疗有着负面的影响.
展开▼
